CASCETTA, PRISCILLA
 Distribuzione geografica
Continente #
NA - Nord America 100
EU - Europa 72
AS - Asia 17
AF - Africa 7
Totale 196
Nazione #
US - Stati Uniti d'America 100
IT - Italia 47
NL - Olanda 14
CI - Costa d'Avorio 7
HK - Hong Kong 6
CN - Cina 5
IN - India 4
GB - Regno Unito 3
CH - Svizzera 2
DE - Germania 2
FR - Francia 2
PK - Pakistan 2
BE - Belgio 1
ME - Montenegro 1
Totale 196
Città #
Chandler 24
Amsterdam 14
Naples 14
Ashburn 12
Fucecchio 4
Lawrence 4
Millbury 4
Pune 4
Casagiove 3
Seattle 3
Boston 2
Des Moines 2
Formia 2
Islington 2
Lahore 2
Leawood 2
Napoli 2
Pomigliano d'Arco 2
Prato 2
San Giorgio a Cremano 2
Wilmington 2
Zurich 2
Bad Krozingen 1
Beijing 1
Edinburgh 1
Falkenstein 1
Houston 1
La Louvière 1
Modica 1
Podgorica 1
Pozzuoli 1
Rho 1
Rozzano 1
San Jose 1
San Mateo 1
Sesto Fiorentino 1
Shanghai 1
Totale 125
Nome #
Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients with FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature Review. 41
FOLFIRINOX after first-line gemcitabine-based chemotherapy in advanced pancreatic cancer: a retrospective comparison with FOLFOX and FOLFIRI schedules 40
Use of folfirinox or nab-paclitaxel plus gemcitabine for the treatment of locally advanced pancreatic adenocarcinoma: A single institution observational study 38
Combining Immune Checkpoint Inhibitors with Anti-Angiogenic Agents 30
The project of the new “chiaia” station of line 6 by peter greenaway and the impact of the “mandatory museum” of the naples underground network 25
FOLFIRINOX or nab-paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: an observational study 20
RET Inhibitors in Non-Small-Cell Lung Cancer 13
Totale 207
Categoria #
all - tutte 970
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 970


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202014 0 0 0 1 2 5 0 0 0 0 2 4
2020/202117 2 0 0 0 3 4 0 0 6 0 2 0
2021/202228 0 0 1 0 0 0 1 2 3 3 10 8
2022/202386 11 11 2 2 6 8 3 11 9 15 5 3
2023/202462 15 12 8 6 2 9 0 10 0 0 0 0
Totale 207